Prot #TK008: Randomized phase III trial of haploidentical HCT with or without an add back strategy of HSV-Tk donor lymphocytes in patients with high risk acute leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date8/22/12 → 6/20/18

Funding

  • CROMSOURCE srl (Prot #TK008 // Prot #TK008)
  • MolMed S.p.A. (Prot #TK008 // Prot #TK008)